Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: Potential of whole tumour ROI and selective ROI analysis

European Journal of Radiology

Volumn 81, Issue 12, 2012, Pages 3870-3876

  Coenegrachts, Kenneth ^a   Bols, Alain ^a   Haspeslagh, Marc ^b   Rigauts, Hans ^a  

^a AZ St Jan Brugge Oostende AV ^*  (Belgium)

^b Hospital Administration and Statistics   (Belgium)

Author keywords

Colorectal liver metastases; DCE MRI; Hot spot analysis; Liver; Selective ROI analysis

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; GADOBENATE DIMEGLUMINE; IRINOTECAN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; CARCINOMA; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84869866354     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2012.07.022     Document Type: Article

References (21)

1. M. Leach, K. Brindle, and J. Evelhoch Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials British Journal of Radiology 76 2003 S87 S91
2. B. Morgan, A. Thomas, and J. Drevs Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies Journal of Clinical Oncology 21 2003 3955 3964
3. W.T. Yuh An exciting and challenging role for advanced contrast MR imaging Journal of Magnetic Resonance Imaging: JMRI 10 1999 221 222
4. J.S. Taylor, P.S. Tofts, and R. Port MR imaging of tumors microcirculation: promise for the new millenium Journal of Magnetic Resonance Imaging: JMRI 10 1999 903 907
5. M.V. Knopp, E. Weiss, and H.P. Sinn Pathophysiologic basis of contrast enhancement in breast tumors Journal of Magnetic Resonance Imaging: JMRI 10 1999 260 266
6. R. Erlemann, J. Sciuk, and A. Bosse Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy Radiology 175 1990 791 796
7. B.D. Fletcher, S.L. Hanna, and D.L. Fairclough Pediatric musculoskeletal tumors: use of dynamic contrast-enhanced MR imaging tomonitor response to chemotherapy Radiology 184 1992 243 248
8. W.E. Reddick, J.S. Taylor, and B.D. Fletcher Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma Journal of Magnetic Resonance Imaging: JMRI 10 1999 277 285
9. J.O. Barentsz, O. Berger-Hartog, and J.A. Witjes Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging Radiology 207 1998 791 797
10. G. Beck, J. De Becker, A. Jones, M. von Falkenhausen, W. Willinek, and J. Gieseke A contrast-enhanced timing robust acquisition order with a preparation of the longitudinal signal component, CENTRA Plus, for 3D contrast enhanced abdominal imaging Journal of Magnetic Resonance Imaging: JMRI 27 2008 1461 1467
11. K. Coenegrachts, J. Ghekiere, and V. Denolin Perfusion maps of the whole liver based on high temporal and spatial resolution contrast-enhanced MRI (4D THRIVE): feasibility and initial results in focal liver lesions European Journal of Radiology 74 2010 529 535
12. D. Rueckert, L. Sonoda, and C. Hayes Non-rigid registration using free-form deformations: application to breast MR images IEEE Transactions on Medical Imaging 18 1999 712 721
13. G. Brix, W. Semmler, R. Port, L. Schad, G. Layer, and W. Lorenz Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging Journal of Computer Assisted Tomography 15 1991 621 628
14. U. Hoffmann, G. Brix, and M. Knopp Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography Magnetic Resonance in Medicine 33 1995 506 514
15. J. Scharf, A. Kemmling, and T. Hess Assessment of hepatic perfusion in transplanted livers by pharmacokinetic analysis of dynamic magnetic resonance measurements Investigative Radiology 42 2007 224 229
16. P. Tofts Modeling tracer kinetics in dynamic Gd-DTPA MR imaging Journal of Magnetic Resonance Imaging: JMRI 7 1997 91 101
17. P. Tofts, G. Brix, and D. Buckley Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols Journal of Magnetic Resonance Imaging: JMRI 10 1999 223 232
18. G. Parker, J. Suckling, and S. Tanner Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics Journal of Magnetic Resonance Imaging: JMRI 7 1997 564 574
19. J.P.B. O'Connor, C.J. Rose, and A. Jackson DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6 British Journal of Cancer 105 2011 139 145
20. C. Hayes, A. Padhani, and M. Leach Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging NMR in Biomedicine 15 2002 154 163
21. O. Noterdaeme, T.A. Leslie, J.E. Kennedy, R.R. Phillips, and M. Brady The use of time to maximum enhancement to indicate areas of ablation following the treatment of liver tumours with high-intensity focused ultrasound British Journal of Radiology 82 2009 412 420